Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset

Anthony J. Furlan, Dirk Eyding, Gregory W. Albers, Yasir Al-Rawi, Kennedy R. Lees, Howard A. Rowley, Christian Sachara, Mariola Soehngen, Steven Warach, Werner Hacke

Research output: Contribution to journalArticlepeer-review

483 Scopus citations

Fingerprint Dive into the research topics of 'Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset'. Together they form a unique fingerprint.

Medicine & Life Sciences